With the holiday season high, there is festive cheer, family gatherings and also an undeniable increases in alcohol consumption that fills the air. Christmas and New Year's Eve celebrations to spring break and bachelor parties and sporting events that bring together huge crowds for celebrations mean that drinking becomes synonymous with partying. But behind the revelry lies a much darker behavior: high-intensity drinking.

Alcohol is the most widely used substance in the United States; it has been reported that 84% of adults aged 18 and older reported lifetime use. Moderate drinking is socially acceptable, but high-intensity drinking is an alarming trend. The behavior of consuming eight or more drinks over a few hours for women and 10 or more for men exceeds binge drinking and significantly increases risk for harm.

High-intensity drinking is far from being just a mere passing concern; it is instead a public health crisis. The burden is even greater as 29 million people in the United States suffer from alcohol use disorder. That has caused over 140,000 deaths annually while accounting for 200,000 hospitalizations and 7.4% of visits to emergency departments in the United States. However, only 7.6% of these affected get treated, thus forming a glaring gap in handling this concern.

What Is High-Intensity Drinking?

High-intensity drinking is a dangerous escalation from traditional binge drinking, characterized by consuming double or triple the standard binge amounts. While binge drinking involves four or more drinks for women and five or more for men, high-intensity drinkers often surpass these levels, leading to blood alcohol concentrations (BAC) exceeding 0.2%—a level that significantly impairs judgment and motor skills.

According to Dr. George Koob, the director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), high-intensity drinking is one of the factors that intensify the risks of injuries, overdose, and death. It is also very highly associated with the onset of AUD, since the chance of addiction increases with increased alcohol consumption per occasion.

Blackouts and Memory Loss Risks

One of the most troubling consequences of high-intensity drinking is alcohol-induced blackouts, periods of amnesia where individuals may appear functional but are incapable of forming memories. Blackouts occur when alcohol disrupts the hippocampus, the brain region responsible for memory formation.

Blackouts are often categorized into two types:

1. Fragmentary Blackouts: Characterized by spotty memory, where recalling certain details can trigger partial recollection.

2. En Bloc Blackouts: Significant amnesia for hours, wherein no memory is created at all, even if tried to be recalled.

Aside from memory loss, intense binge drinking is linked with poor decision-making, violence, injury, and conflicts in personal relationships.

Why Holidays and Special Events Are Hotbeds for Excessive Drinking

Holidays and celebrations create the perfect storm for high-intensity drinking. According to research, adults drink nearly double the amount of alcohol during holidays like Christmas and New Year's Eve than they do at any other time of the year. It is during these periods of social gathering, holiday stress, and seasonal sadness that people drink in excess.

For college students, experiences like spring break and 21st birthdays increase the danger. Some studies indicate that students, especially those who travel with buddies to spring break, indulge in more alcohol and make more serious decisions than any student who remains at home or goes with their family to other destinations. Sporting events are, too, notorious for promoting drunk consumption, especially among male customers. Alcohol consumption usually goes high during Super Bowl Sunday, thus leading to games day violence and arrests.

Consequences of Heavy Intensity Drinking

High-intensity drinking impacts not only physical health and mental well-being but also social relationships.

Acute Risks

- Alcohol poisoning

- Severe dehydration and electrolyte imbalances

- Hypoglycemia

- Risky sexual behavior

- Injuries and accidents

Chronic Risks

- Liver damage, alcoholic hepatitis, and cirrhosis

- Cardiovascular diseases such as arrhythmias and cardiomyopathy

- Neurological damage, including memory deficits and blackouts

- Progression to alcohol dependence or AUD

Psychological Impact

High-intensity drinking is strongly linked with increased risks of depression, anxiety, and suicidal ideation. Poor decision-making during episodes can lead to long-lasting consequences, including damaged academic, professional, or personal outcomes.

How to Address the Problem

Combating high-intensity drinking requires education, early intervention, and accessible treatment options. The NIAAA has defined high-intensity drinking to be distinct from binge drinking and has called for targeted approaches to decline prevalence and associated harms.

One promising treatment option is naltrexone, which a medication helps control alcohol cravings. Encouraging in preliminary evidence, more extensive clinical trials will be necessary to ascertain its efficacy more specifically in high-intensity drinkers.

As we head into the holiday season and other special occasions, it is important to heighten awareness of the dangers of high-intensity drinking. A good understanding of long-term consequences and seeking help when alcohol-related issues arise can be the difference between life and death. Celebrations should be about joy and connection, not about the gateway to harm.

If you or someone you know drinks at dangerous levels or have an alcohol use disorder, there is help available. Remember, for suspected cases of alcohol poisoning, dial 911. In this way, we can foster healthier relationships with alcohol and create safer environments for everyone.

Bariatric surgery has been around for more than 50 years, yet it remains one of the most misunderstood areas of modern medicine. What started as a last resort for weight loss has grown into a highly researched and effective way to treat serious metabolic diseases. Even after all this time, the procedure is still buried under a lot of social stigma and medical myths.

Many people still avoid it, thinking it as an easy way out or something people do just for looks. However, in reality, it is a complex biological reset that targets the hormones driving obesity, rather than just making the stomach smaller.

As obesity rates climb globally, the gap between what the science says and what the public believes keeps millions from a treatment that could save their lives. Research from the American Society for Metabolic and Bariatric Surgery (ASMBS) shows that patients who choose this path can reduce their risk of an early death by 30% to 50%.

Deconstructing The Myths Of The Easy Way Out

Myth 1: Obesity is about a lack of willpower

The biggest mistake people make is thinking obesity is just a lack of discipline. In reality, the body has an internal set point that fights against long term weight loss from just dieting.

Myth 2: It is not safe

Many fear these operations are dangerous, but the reality has changed. Thanks to modern robotic tools, the complication rate is only about 4%.

Myth 3: It is a beauty treatment

While losing weight is the most obvious result, the real goal is to get healthy. This procedures is also used to treat other health conditions like Type 2 diabetes, high blood pressure, and sleep apnea.

Myth 4: There are instant results

This is not a magic fix where the person does not do anything. It requires a lifelong commitment to new eating habits, taking daily vitamins, and staying active. Without these lifestyle changes, the physical benefits the surgery provides can fade over time.

Choosing The Right Surgical Options And Clinical Outcomes

Choosing the right procedure is a decision based on a person’s specific health profile. The two most common surgeries today have been refined over decades to prioritize safety and long-term success.

1. Sleeve Gastrectomy: This is currently the most opted choice which involves removing about 80% of the stomach, which lowers the production of hunger hormones. It’s a shorter surgery with a very low complication rate.

2. Gastric Bypass: This is often considered the gold standard for treating severe Type 2 diabetes. Rerouting the small intestine, it creates a more powerful metabolic shift that helps control blood sugar almost immediately.

3. Biliopancreatic Diversion (BPD/DS): Reserved for more complex cases, this offers the highest level of weight loss and diabetes remission but requires the strictest adherence to vitamin and protein intake.

4. Long Term Durability: Unlike many temporary fixes, data shows that five to twenty years after surgery, the majority of patients maintain a significant portion of their weight loss and keep their metabolic diseases under control.

The Physiological Shift: Beyond Mechanical Restriction

In the early days, these procedures were mostly about restriction - simply making the stomach smaller so a person couldn't eat as much. Today, we know it's much more about the chemistry. When the digestive path is changed, the way the gut and brain talk to each other is completely transformed. This biochemical shift is why many see their Type 2 diabetes disappear almost immediately, sometimes even before they've lost much weight. The surgery turns down the volume on intense cravings and turns up the signals that tell the brain the body is full.

These changes also help the heart and the rest of the endocrine system. By lowering inflammation and helping the body use insulin better, the risk of heart attacks and strokes drops significantly.

The benefits aren't just about a smaller number on the scale; it’s about a total change in how the body handles energy. This allows a person to maintain a healthier weight because their body is no longer fighting against them, thinking it’s starving.

Societal Barriers And The Future Of Metabolic Health

The reason these myths stick around is because society tends to judge people based on their weight. When obesity is treated as a character flaw instead of a chronic illness, surgery is seen as a shortcut. But for someone with a Body Mass Index (BMI) over 40, the chances of reaching a healthy weight through lifestyle changes alone is less than 1%.

With the advancement in technology, we need to stop talking about weight loss and start talking about metabolic health. We are moving toward early access, which means treating metabolic issues before they cause permanent damage to the heart or kidneys. Clearing up these 50-year-old myths isn't just about setting the record straight, it’s a necessary step for public health.

An interesting yet alarming trend is being observed in people who are losing weight with Mounjaro, loose skin, or popularly known as Mounjaro Face.

Post Mounjaro/Ozempic, many patients are now reporting a face that’s saggy or making them look 10 years older.

Mounjaro Face

Neha, a 34-year-old MNC executive who came to us saying, “Doc, now that I have Zoom calls and everything, I’ve lost almost 20–30 kgs in the last 9 months. My weight has plateaued, but one thing I have noticed is that I have that ‘Mounjaro/ Ozempic face,’ which I read in one of the newspaper articles.”

“Ozempic face” or “Mounjaro face” is becoming pretty common nowadays. The problem lies in the fact that the facial volume has been reduced.

The looseness of the skin accentuates the effects of weight loss. It also depends on the age and genetics of an individual. Usually, patients who are taking high doses of Mounjaro and have lost significant weight in a short span are more susceptible to facial changes like looseness of skin and loss of volume.

Why Does It Happen?

Mounjaro or Ozempic are semaglutides, which are GLP-1 agonists that act on the body to deplete body fat. It also has an impact on facial compartments, which have facial fat, include superficial and deep fat that support the face.

When these compartments are depleted of fat, it shows as hollowness, especially in the under-eye region or the cheek region. You may have a sharp jawline, but with saggy skin.

After 40 years, older patients have less collagen and elastin, so they adapt poorly to fat loss and therefore, the extent can be prominent. Also, faster weight drops with a slimmer baseline face are affected more by it.

Vitamin, mineral, and protein deficiency, along with dehydration, can be contributory factors.

How Can I Prevent It?

Well, if you are on Ozempic or Mounjaro-like drugs, make sure your protein intake is adequate. Most doctors would like to keep it around 1.5 g to 2 g per kg body weight, depending on the patient’s health condition.

Another crucial aspect is strength training, especially to maintain muscle mass.

Essential intake of supplements like vitamins, minerals, and collagen can also help in maintaining skin structure.

If you’re experiencing early laxity of the skin, like early skin looseness or prominent nasolabial lines, then radiofrequency, MIcroneedling, HIFU, and similar technologies might work.

In some cases, fillers and threads can help you, but these are not long-term measures.

In cases where there is loss of complete elasticity, the treatment remains surgical, which, depending on the extent, can be a full or mini facelift. In this, not only is facial skin tightened, but also the deeper muscle layer is tightened. To restore the volume, many patients opt for facial fat transfer, where the body’s own fat can be used to augment lost volume in the face.

Confidence And Self-esteem

Confidence is not just about losing weight; it’s also about regaining your self-esteem.

Whenever someone is on Mounjaro or Ozempic, it is pertinent to take care of all the other factors and make sure it is properly monitored, so that your skin doesn’t sag and you don’t look older.

Metabolism-Associated Fatty Liver Disease (MAFLD) — also termed Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) — is defined by excess hepatic fat accumulation (>5 per cent of liver weight) in the presence of metabolic dysfunction, independent of alcohol intake. It encompasses a spectrum from simple steatosis to steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma.

MAFLD: Epidemiology In India

A Lancet Regional Health study found that approximately 39 per cent of Indian adults screened had fatty liver disease, making it one of the most prevalent chronic liver conditions in the country. Within India, prevalence shows regional variation driven by genetic, dietary, and socioeconomic factors.

A particularly important feature is the “lean MAFLD” phenotype — South Asians often develop fatty liver at a lower BMI due to disproportionately high visceral fat, which complicates detection based on conventional BMI screening. Currently, MASLD is the commonest cause of liver cirrhosis and hepatocellular carcinoma (HCC).

MAFLD: Causes And Risk Factors

The core drivers are components of metabolic syndrome: type 2 diabetes mellitus, obesity (particularly central adiposity), dyslipidemia, hypertension, and insulin resistance. MASLD is strongly linked to obesity, sedentary lifestyles, and metabolic syndrome.

Genetic susceptibility also plays a role — variants in genes such as PNPLA3 are associated with increased liver fat accumulation, particularly in certain Indian populations. Rapid dietary transition towards ultra-processed, high-calorie foods compounds the risk.

MAFLD: Investigations

Routine liver function tests may appear normal in early stages, and an ultrasound detects only moderate-to-severe fat accumulation. A structured approach includes:

• Blood tests: LFTs, fasting glucose, HbA1c, lipid profile, insulin resistance indices
• Ultrasound abdomen: First-line imaging for steatosis
• FibroScan (Transient Elastography): Liver stiffness measurement (LSM) and controlled attenuation parameter (CAP) are standardized non-invasive tools for assessing fibrosis and steatosis.
• Liver biopsy: Gold standard for staging steatohepatitis and fibrosis when non-invasive tests are inconclusive.

MAFLD: Treatment

No approved pharmacotherapy exists exclusively for MAFLD; management is lifestyle-centred:

• Weight loss: 7–10 per cent body weight reduction significantly reduces hepatic steatosis and inflammation
• Diet: Mediterranean-style diet; restrict refined carbohydrates and saturated fats
• Exercise: Both aerobic and resistance training improve insulin sensitivity and liver fat
• Metabolic comorbidity control: Optimise glycaemia (GLP-1 agonists show hepatic benefit), manage dyslipidaemia and hypertension
• Emerging therapies: Resmetirom (thyroid hormone receptor-β agonist) has shown promise in MASH with fibrosis.